FDA Recalls Compounded Testosterone Injection for Sterility Assurance
Tailor Made Compounding is recalling 93 vials of Testosterone Enanthate due to lack of assurance of sterility. The affected batches were distributed nationwide and in Puerto Rico.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving lack of sterility assurance in an injectable medication, which is a risk-of-harm product. Per the rubric, a Class II recall without reported hospitalization or injury falls under High when the product poses a risk of harm but no illness has yet been reported.
Plain-English summary
Tailor Made Compounding has recalled Testosterone Enanthate (GSO) 100 mg/ml compounded injectable medication due to lack of assurance of sterility. The recall affects 93 vials from two batches: Batch 11102106A1 (expiration 4/30/2022) and Batch 01142230A1 (expiration 7/13/2022).
The medication was distributed nationwide throughout the United States and in Puerto Rico. The FDA has classified this as a Class II recall. Consumers or healthcare providers who have received this product should discontinue use and contact Tailor Made Compounding or their healthcare provider for information about disposal and next steps.
The recalled product
- Product
- Testosterone Enanthate (GSO) 100mg/ml, 2 mL-vial, Room temperature, Tailor Made Compounding
- Manufacturer
- TMC Acquisition LLC dba Tailor Made Compounding
- Category
- Drug — Compounded Injection
- Hazard
- sterility-failure
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Batch#: 11102106A1
- Exp 4/30/2022
- 01142230A1
- Exp 7/13/2022.
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModeratePovi-One Povidone-Iodine 10% Topical Drug Recall for Sub Potency
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01